國家衛生研究院 NHRI:Item 3990099045/9718
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 911730      Online Users : 968
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
    •  Adv. Search
    Home ‧ Login ‧ Upload ‧ Help ‧ About ‧ Administer Goto mobile version


    Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/9718


    Title: Cisd2 haploinsufficiency leads to non-alcoholic fatty liver disease (NAFLD) and accelerates hepatocarcinogenesis in mice
    Authors: Kao, CH;Shen, ZQ;Chen, YF;Tsai, TF
    Contributors: Institute of Molecular and Genomic Medicine
    Abstract: Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease. Hepatic steatosis (fatty liver) is a vulnerable factor that could lead to liver damage, inflammation, fibrosis, cirrhosis and hepatocellular carcinoma (HCC). However, despite the high prevalence of NAFLD, the genetic factor determining the disease progression remains poorly understood. CISD2 is a previously uncharacterized novel gene located within the overlapping region of HCC critical region and human longevity region on chromosome 4q. We have recently demonstrated for the first time that Cisd2 is a mitochondrial outer membrane protein which mediates mitochondrial integrity and lifespan in mammals. Surprisingly, we have observed phenotype similar to NAFLD in the liver of Cisd2 heterozygous (+/−) knockout mice. Cisd2 haplo-insufficiency led to abnormal lipid metabolism accompanying with fatty liver, cell death, severe inflammation and fibrosis in the liver. Moreover, there was a low incidence (1/18; 5.6%) of HCC developed at 16-18 months of age in the Cisd2+/− mice. Interestingly, our results revealed a significant increase of the Srebp1c which is the master regulator of lipogenesis; the increase in Srebp1-c seems to further up-regulate the expression of its target gene, fatty acid synthase (Fas), in the Cisd2+/− livers. In addition, we found that liver fibrosis was associated with activation of hepatic stellate cells, as revealed by increased expression of α-ΣMA, in the Cisd2+/− livers. Furthermore, we provide evidence that Cisd2 haplo-insufficiency promoted hepatocarcinogenesis and accelerated HCC development by 4-6 months in the transgenic mice expressing HBV X protein. In summary, our results suggested that Cisd2 is likely to be a haplo-insufficient tumor suppressor gene for HCC. Heterozygous deficiency of Cisd2 led to NAFLD, and accelerated the progression of HBV-associated HCC. Our data suggest that Cisd2 is a molecular target for the development of chemoprevention and therapeutic strategy for NAFLD.
    Date: 2012-04
    Relation: Cancer Research. 2012 Apr;72:Abstract number 1332.
    Link to: http://dx.doi.org/10.1158/1538-7445.am2012-1332
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0008-5472&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000209701504377
    Appears in Collections:[Others] Conference Papers/Meeting Abstract

    Files in This Item:

    File Description SizeFormat
    ISI000209701504377.pdf26KbAdobe PDF356View/Open


    All items in NHRI are protected by copyright, with all rights reserved.

    Related Items in TAIR

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback